The primary goal of the Research Institute of Biopharmaceutical Sciences is the discovery, engineering, analysis and characterisation of the mode of action of biopharmaceuticals of high commercial and therapeutic value.
Biopharmaceuticals, also known as biologics, are therapeutic drugs such as proteins that are typically made in living cells, in contrast to most pharmaceuticals, which are chemically synthesised.
The RIBS works closely with selected companies in BioBay to add value to existing commercial ventures where the identified problems are of mutual and general relevance.
An important feature of the institute is its multi-disciplinary teams, consisting of core members, industrial researchers and invited international researchers, which accelerate progress and facilitate innovation and knowledge exchange.Find out more
Our research staff are working on a number of projects focussed on bioinformatics, G protein-coupled receptors, targeting the mycobacterial cell envelope and T-cells amongst others.Find out more